e-Article
Vepafestinib is effective in preclinical models of sarcomas with RET fusion including a brain metastasis model
Document Type
Article
Author
Source
In: European Journal of Cancer , 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics. (European Journal of Cancer, October 2022, 174:S27)
Subject
Language
English
ISSN
18790852
09598049
09598049